Analysts Set Mereo BioPharma Group plc (NASDAQ:MREO) PT at $7.71
Shares of Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) have been assigned a consensus rating of “Buy” from the eight research firms that are presently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. […]
Shares of Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) have been assigned a consensus rating of “Buy” from the eight research firms that are presently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. […]